Ximelagatran for secondary prevention of venous thromboembolism

被引：0
|
作者：
Böger, C [1 ]
Schroll, S [1 ]
Holmer, S [1 ]
机构：
[1] Klinikum Univ Regensburg, D-93042 Regensburg, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [1] Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran
    Schulman, S
    Wåhlander, K
    Lundström, T
    Clason, SB
    Eriksson, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (18): : 1713 - 1721
  • [2] Extended secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran
    Wahlander, K
    Lundström, T
    Eriksson, H
    Schulman, S
    [J]. ATHEROSCLEROSIS, 2003, 170 (01) : S7 - S8
  • [3] Secondary prevention of venous thromboembolism
    Schulman, Sam
    Douketis, James
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [4] Secondary prevention of venous thromboembolism
    Bauersachs, R. M.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (40) : 1994 - 1997
  • [5] Ximelagatran for the secondary prevention of venous thromboembolism -: A complementary follow-up analysis of the THRIVE III study
    Schulman, S
    Lundström, T
    Wåhlander, K
    Clason, SB
    Eriksson, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) : 820 - 824
  • [6] The role of ximelagatran in the treatment of venous thromboembolism
    Schulman, S
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 : 18 - 24
  • [7] Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism
    Wåhlander, K
    Eriksson, H
    Lundström, T
    Clason, SB
    Wall, U
    Nyström, P
    Wessman, P
    Schulman, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (01) : 68 - 77
  • [8] Ximelagatran/MelagatranA Review of its Use in the Prevention of Venous Thromboembolism in Orthopaedic Surgery
    Hannah C. Evans
    Caroline M. Perry
    Diana Faulas
    [J]. Drugs, 2004, 64 : 649 - 678
  • [9] Ximelagatran/melagatran - A review of its use in the prevention of venous thromboembolism in orthopaedic surgery
    Evans, HC
    Perry, CM
    Faulds, D
    [J]. DRUGS, 2004, 64 (06) : 649 - 678
  • [10] Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement
    Francis, CW
    Berkowitz, SD
    Comp, PC
    Lieberman, JR
    Ginsberg, JS
    Paiement, G
    Peters, GR
    Roth, AW
    McElhattan, J
    Colwell, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (18): : 1703 - 1712
12345